Skip to main content

arrhythmia

Vanderbilt collaboration yields promising compound to treat arrhythmia

Feb. 21, 2019—In addition to establishing potency, the team’s tests on cells and, later, mice showed that even high doses of the compound caused no ill effects.

Read more


New view of the heartbeat

Apr. 6, 2018—Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.

Read more


VUMC testing device to reduce stroke risk in arrhythmia patients

Feb. 9, 2017—Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia.

Read more


Knollmann to direct new arrhythmia research center

Jan. 14, 2016—Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).

Read more


Normalizing calcium flux to treat atrial fibrillation

May. 12, 2014—A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.

Read more


Reducing fatal rhythms after heart attack

Jul. 26, 2013—Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

Read more


Rhythm response tied to gene variant

Jun. 21, 2013—A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.

Read more


Patient undergoes surgical first to treat his arrhythmia

Apr. 11, 2013—The state of Michael Stanbery’s health was shocking.

Read more


Study tracks genes involved in heart rhythm disorders

Feb. 7, 2013—A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm.

Read more


Green tea for failing hearts?

Nov. 16, 2012—The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.

Read more


Key to a woman’s heart (condition)?

Aug. 10, 2012—Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.

Read more


Common antibiotic found to pose increased heart risk

May. 21, 2012—Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack.” The study found a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all.

Read more


Upcoming Events

MORE EVENTS »